Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome
Open Access
- 1 March 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (5), 1459-1465
- https://doi.org/10.1158/1078-0432.ccr-06-2032
Abstract
Purpose: To assess the feasibility of predicting neuroblastoma outcome using highly parallel quantitative real-time PCR data. Experimental Design: We generated expression profiles of 63 neuroblastoma patients, 47 of which were analyzed by both Affymetrix U95A microarrays and highly parallel real-time PCR on microfluidic cards (MFC; Applied Biosystems). Top-ranked genes discriminating patients with event-free survival or relapse according to high-level analysis of Affymetrix chip data, as well as known neuroblastoma marker genes (MYCN and NTRK1/TrkA), were quantified simultaneously by real-time PCR. Analysis of PCR data was accomplished using high-level bioinformatics methods including prediction analysis of microarray, significance analysis of microarray, and Computerized Affected Sibling Pair Analyzer and Reporter. Results: Internal validation of the MFC method proved it highly reproducible. Correlation of MFC and chip expression data varied markedly for some genes. Outcome prediction using prediction analysis of microarray on real-time PCR data resulted in 80% accuracy, which is comparable to results obtained using the Affymetrix platform. Real-time PCR data were useful for risk assessment of relapsing neuroblastoma (P = 0.0006, log-rank test) when Computerized Affected Sibling Pair Analyzer and Reporter analysis was applied. Conclusions: These data suggest that multiplex real-time PCR might be a promising approach to reduce the complexity of information obtained from whole-genome array experiments. It could provide a more convenient and less expensive tool for routine application in a clinical setting.Keywords
This publication has 31 references indexed in Scilit:
- Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeJNCI Journal of the National Cancer Institute, 2006
- Potential Application of ELAVL4 Real-Time Quantitative Reverse Transcription-PCR for Detection of Disseminated Neuroblastoma CellsClinical Chemistry, 2006
- Transcriptional Signatures of Normal Human Mammary Epithelial Cells in Response to Benzo[a]pyrene Exposure: A Comparison of Three Microarray PlatformsOMICS: A Journal of Integrative Biology, 2005
- Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisitedBiostatistics, 2005
- Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingOncogene, 2005
- Patient-based cross-platform comparison of oligonucleotide microarray expression profilesLaboratory Investigation, 2005
- Dimension reduction methods for microarrays with application to censored survival dataBioinformatics, 2004
- Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six GenesNew England Journal of Medicine, 2004
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993